Jonathan Lim Yamzon, M.D.
Urologic Oncology Surgeon
4.9 (137 RATINGS)
Clinical Expertise
Prostate Cancer
Kidney Cancer
Bladder Cancer
Testicular Cancer
Research Area
Urologic Oncology
Appointments
Associate Clinical Professor, Division of Urology and Urologic Oncology, Department of Surgery
Additional Contacts
Referring Physicians/Colleagues
At City of Hope since 2011, Dr. Yamzon performs open and minimally invasive surgical procedures on a variety of urologic cancers. He is additionally trained in robotic surgery, having completed a robotic surgery fellowship at City of Hope.
A graduate of the Keck School of Medicine of USC, Dr. Yamzon’s clinical focus includes the treatment of prostate, kidney, bladder and testis cancer. His interests include new biomarkers and technologies that look to improve the diagnosis and treatment of genitourinary cancers and enhance the delivery of personalized care.
Medical Board of California
Drug Enforcement Agency
2004, Bachelor of Science, bioengineering, cum laude, Keck School of Medicine of USC, Doctor of Medicine
2000, University of California San Diego, La Jolla, CA
2010-2011, Fellowship in Urologic Oncology, City of Hope, Duarte, CA,
2004-2010, Los Angeles County/University of Southern California, Residency in Urology
2023-present, Associate Clinical Professor, Division of Urologic Oncologic Surgery, Department of Surgery, City of Hope, Duarte, CA
2011-2023, Assistant Clinical Professor, Division of Urologic Oncologic Surgery, Department of Surgery, City of Hope, Duarte, CA
2011-present, Staff Surgeon, Division of Urologic Oncologic Surgery, City of Hope, Duarte, CA
2011-present, Staff Surgeon, Division of Urologic Oncologic Surgery, City of Hope, Antelope Valley Hospital, Lancaster, CA
2011-present, Staff Surgeon, Division of Urologic Oncologic Surgery, City of Hope, Huntington Memorial Hospital, South Pasadena, CA
2011-present, Staff Surgeon, Division of Urologic Oncologic Surgery, Garfield Medical Center, Monterey Park, CA
2011-present, Staff Surgeon, Division of Urologic Oncologic Surgery, San Antonio Hospital, Ontario, CA
2004-2010, Resident Clinical Instructor: Introduction to Clinical Medicine, Keck School of Medicine of USC
American Urologic Association
Los Angeles Urological Society
Salerni Collegium Faculty Alumni Association
Golden Key Nation Honor Society
- Bosserman LD, Cianfrocca M, Yuh B, Yeon C, Chen H, Sentovich S, Polverini A, Zachariah F, Deaville D, Lee AB, Sedrak MS, King E, Gray S, Morse D, Glaser S, Bhatt G, Adeimy C, Tan T, Chao J, Nam A, Paz IB, Kruper L, Rao P, Sokolov K, Kulkarni P, Salgia R, Yamzon J, Johnson D. Integrating Academic and Community Cancer Care and Research through Multidisciplinary Oncology Pathways for Value-Based Care: A Review and the City of Hope Experience. J Clin Med. 2021 Jan 7;10(2):188. doi: 10.3390/jcm10020188.PMID: 33430334
- Burg ML, Yamzon J, Li WY. Full thickness penile skin necrosis following HIPEC: Case report and literature review. Urol Case Rep. 2020 Oct 6;34:101430. doi: 10.1016/j.eucr.2020.101430. eCollection 2021 Jan.
- Gilligan T, Lin DW, Aggarwal R, Chism D, Cost N, Derweesh IH, Emamekhoo H, Feldman DR, Geynisman DM, Hancock SL, LaGrange C, Levine EG, Longo T, Lowrance W, McGregor B, Monk P, Picus J, Pierorazio P, Rais-Bahrami S, Saylor P, Sircar K, Smith DC, Tzou K, Vaena D, Vaughn D, Yamoah K, Yamzon J, Johnson-Chilla A, Keller J, Pluchino LA. Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019 Dec;17(12):1529- 1554. doi: 10.6004/jnccn.2019.0058. PMID: 31805523
- Shen JK, Jamnagerwalla J, Yuh BE, Bassett MR, Chenam A, Warner JN, Zhumkhawala A, Yamzon JL, Whelan C, Ruel NH, Lau CS, Chan KG. Real-time indocyanine green angiography with the SPY fluorescence imaging platform decreases benign ureteroenteric strictures in urinary diversions performed during radical cystectomy. Ther Adv Urol. 2019 Apr 4;11:1756287219839631. doi: 10.1177/1756287219839631. eCollection 2019 Jan-Dec. PMID: 31057669
- Chenam A, Parihar JS, Ruel N, Pal S, Avila Y, Yamzon J, Lau C, Yuh B. Lymph node-positive prostate cancer after robotic prostatectomy and extended pelvic lymphadenectomy. J Robot Surg. 2018 Sep;12(3):425-431. doi: 10.1007/s11701-017-0751-8. Epub 2017 Sep 13. PMID: 28905289
- Chenam A, Yuh B, Zhumkhawala A, Ruel N, Chu W, Lau C, Chan K, Wilson T, Yamzon J. Prospective randomised non-inferiority trial of pelvic drain placement vs no pelvic drain placement after robot-assisted radical prostatectomy. BJU Int. 2018 Mar;121(3):357-364. doi: 10.1111/bju.14010. Epub 2017 Sep 22. PMID: 28872774 (JIF: 4.439)
- Chennamsetty A, Zhumkhawala A, Tobis SB, Ruel N, Lau CS, Yamzon J, Wilson TG, Yuh BE. Lymph Node Fluorescence During Robot-Assisted Radical Prostatectomy With Indocyanine Green: Prospective Dosing Analysis. Clin Genitourin Cancer. 2017 Aug;15(4):e529-e534. doi: 10.1016/j.clgc.2016.10.014. Epub 2016 Nov 16. PMID: 27939590 (JIF: 2.535)
- Gin GE, Ruel NH, Parihar JS, Warner JN, Yuh BE, Yamzon J, Wilson TG, Lau CS, Chan KG. Ureteroenteric anastomotic revision as initial management of stricture after urinary diversion. Int J Urol. 2017 May;24(5):390-395. doi: 10.1111/iju.13323. Epub 2017 Mar 12. PMID: 28295645
- Wittig K, Yamzon JL, Smith DD, Jeske DR, Smith SS. Presurgical Biomarker Performance in the Detection of Gleason Upgrading in Prostate Cancer. Cancer Epidemiol Biomarkers Prev. 2016 Dec;25(12):1643-1645. Epub 2016 Aug 19. PubMed PMID: 27543619.
- Gin G, Parihar G, Yuh B, Yamzon J, Lau C, Chan KG. PD-12-03 Primary Ureteroenteric Anastomotic Revision after urinary Diversion. J. Urol April 2016; 195(4):e293-e294. DOI:10.1016/j.juro.2016.02.898.
- Kardos SV, Chan KG, Yuh B, Yamzon J, Ruel NH, Zachariah F, Lau CS, Crocitto L. PD02-02 Enhanced recovery after surgery and care coordination pathway at city of hope: Decreased length of stay, readmissions, and complications. J. Urol April 2016; 195(4s):e51. DOI:10.1016/j.juro.2016.02.2076.
- Bourque J, Chan KG, Wilson T, Lau C, Yuh B, Yamzon J. MP64-08 Establishing a care coordination Pathway for bladder cancer Cystectomy patients. J. Urol. 2015 April; 193(4):e800-e801. DOI: 10.1016/j.juro.2015.02.2319
- Yuh B, Torrey RR, Ruel NH, Wittig K, Tobis S, Linehan J, Lau CS, Chan KG, Yamzon J, Wilson TG. Intermediate-term oncologic outcomes of robot-assisted radical cystectomy for urothelial carcinoma. J Endourol. 2014 Aug;28(8):939-45. doi: 10.1089/end.2014.0073. Epub 2014 Apr 16. PubMed PMID: 24635448. (JIF: 2.270)
- Linehan J, Yamzon J, Wilson T, Smith S. The role of expressed prostatic secretion biomarkers in prostate cancer screening/surveillance. CLI Feb/March 2014, Pages 23-25
- Nazmy M, Yuh B, Kawachi M, Lau CS, Linehan J, Ruel NH, Torrey RR, Yamzon J, Wilson TG, Chan KG. Early and Late Complications of Robotic Assisted Radical Cystectomy: A Standardized Analysis by Urinary Diversion Type. J Urol. 2014 Mar; 191(3):681-7. doi: 10.1016/j.juro.2013.10.022. Epub 2013 Oct 4. PMID: 24099746 (JIF: 5.157)
- Pal SK, Yamzon J, Sun V, Carmichael C, Saikia J, Ferrell B, Frankel P, Hsu J, Twardowski P, A. Stein CA, Margolin K. Paclitaxel-Based High-Dose Chemotherapy with Autologous Stem cell rescue for Relapsed Germ Cell Tumor: Clinical Outcome and quality of Life in Long-Term Survivors. Clinical Genitourinary Cancer 2013, June 11(2):121-7. (JIF: 2.535)
- Pal SK, Yamzon J, Sun V, Carmichael C, Saikia J, Ferrell B, Frankel P, Hsu J, Twardowski P, A. Stein CA, Margolin K. Paclitaxel-Based High-Dose Chemotherapy with Autologous Stem cell rescue for Relapsed Germ Cell Tumor: Clinical Outcome and quality of Life in Long-Term Survivors. Clinical Genitourinary Cancer 2013, June 11(2):121-7. (JIF: 2.535)
- Nazmy M, Wilson T, Yuh B, Lau C, Yamzon J, Torrey R, Linehan J, Ruel N, Chan K. Complications of Robotic Assisted Radical Cystectomy by Diversion Type. The Journal of Urology 04/2013; 189(4):e724. (JIF: 5.157)
- Nazmy M, Lau C, Kawachi M, Yuh B, Yamzon J, Ruel R, Wilson T. Very Low Risk and Low Risk Prostate Cancer Survival After Robotic Prostatectomy The Journal of Urology 04/2013; 189(4):e612. (JIF: 5.157)
- Pal SK, Yamzon J, Sun V, Carmichael C, Saikia J, Ferrell B, Frankel P, Hsu J, Twardowski P, A Stein CA, Margolin K. Paclitaxel-Based High-Dose Chemotherapy with Autologous Stem Cell Rescue for Relapsed Germ Cell Tumor: Clinical Outcome and Quality of Life in Long-Term Survivors. Clinical Genitourinary Cancer 10/2012; 11(2). (JIF: 2.535)
- Nazmy M, Lau C, Wilson T, Yamzon J. Gleason Score Upgrading in NCCN Very Low Risk Classification Prostate Cancer Patients, The Journal of Urology 04/2012; 187(4):e284. (JIF: 5.157)
- Nazmy M, Yuh B, Chan K, Lau C, Yamzon J, Linehan J, Torrey R, Kawachi M, Wilson T. Perioperative Complications of Robotic Radical Cystectomy and Urinary Diversion Within 90 Days of Surgery. The Journal of Urology 04/2012; 187(4):e710. (JIF: 5.157)
- Lau CS, Torrey RR, Yuh B, Linehan J, Whelan C, Yamzon J, Yip W, Ruel N, Wilson T, Josephson DY. Robotic-assisted laparoscopic partial nephrectomy: experience in lesions larger than 4 cm European Urology Supplements 10/2011; 10(8):542-542.
- Josephson DY, Torrey RR, Lau CS, Yuh B, Linehan J, Yamzon J, Whelan C, Kawachi M, Wilson T. The use of near-infrared fluorescence imaging during robotic-assisted laparoscopic partial nephrectomy: initial clinical applications and experience at City of Hope Cancer Center. European Urology Supplements 10/2011; 10(8):542-542.
- Yamzon J, Ruel N, Yuh B, Torrey R, Whelan C, Linehan J, Lau C, Wilson T, Josephson D. Laparoscopic and Robotic-Assisted Laparoscopic Radical Prostatectomy in Clinically High-Risk Localized Prostate Cancer at a Single Institution The Journal of Urology 04/2011; 185(4):e266. (JIF: 5.157)
- Yamzon J, Lee KH, Kuremoto K, Choi I-S, Parsa S, Bellusci S, Warburton D, Koh C. FGF10/FGFR2B Signaling During Acute Cyclophosphamide-Induced Bladder Urothelial Injury in Mice. The Journal of Urology 04/2011; 185(4). (JIF: 5.157)/li>
- Chung S, Kang DO, Yamzon J, Warburton D, Koh CJ. O-GlcNAc mediated glycosylation downregulation in mice with cyclophosphamide induced cystitis. J Urol. 2010 Jan;183(1):351-6. doi: 10.1016/j.juro.2009.08.102. PMID:19914650 (JIF: 5.157)
- Dorin R, Yamzon J, Koh C. (2010) “Embryonic Stem Cells, Nuclear Transfer, and Parthenogenesis Derived Stem Cells for Urologic Reconstruction”, in Denstedt J and Atala A, Biomaterials and Tissue Engineering in Urology, Cambridge, Woodhead Publishing.
- Chung S, Kang D, Yamzon J, Warburton D, Koh CJ. O-GlcNAc Mediated Glycosylation Down-Regulation in Mice With Cyclophosphamide Induced Cystitis The Journal of urology 11/2009; 183(1):351-6. (JIF: 5.157)
- Yamzon J, Chung S, Kang D, Kokorowski P, Kuremoto K, Koh CJ. Fibroblast Growth Factor 10-Mediated Delay in Bladder Wound Healing in Inducible Transgenic Mice. The Journal of Urology 04/2009; 181(4):235-235 DOI:10.1016/ S0022- 5347(09)60668-6 (JIF: 5.157)
- Yamzon J, Kokorowski P, DeFilippo RE, Chang AY, Hardy BE, Koh CJ. 2008. Pediatric robot assisted laparoscopic excision of urachal cyst and bladder cuff. Journal of endourology / Endourological Society 11/2008; 22(10):2385-8; discussion 2388. DOI:10.1089/end.2008.0338
- Yamzon J, Perin L, Koh CJ. Current status of tissue engineering in pediatric urology. Current Opinions In Urology 07/2008; 18(4): 404-7. DOI:10.1097/MOU.0b013e328302f0e1
- Yamzon J, Kokorowski P, Koh CJ. Stem cells and tissue engineering applications of the genitourinary tract. Pediatric Research 06/2008; 63(5):472-7. DOI:10.1203/PDR.0b013e31816a704a
- Kimbrell BJ, Yamzon J, Petrone P, Asensio JA, Velmahos GC. 2007. Intrapleural thrombolysis for the management of undrained traumatic hemothorax: a prospective observational study. Journal of Trauma 62(5): 1175-8 (JIF: 3.434)
- Quek ML, Nichols PW, Yamzon J, Daneshmand S, Miranda G, Cai J, Groshen S, Stein JP, Skinner DG. 2005. Radical cystectomy for primary neuroendocrine tumors of the bladder: the University of Southern California experience. Journal of Urology 174(1):93-6. OI:10.1097/01.ju.0000162085.20043.1f (JIF: 5.157)
Ratings and reviews below are gathered from the Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS) survey. CG CAHPS is a standardized survey that is used to measure a patient's experience in the physician office setting. Ratings are an average of all responses to questions about a provider's care, with 5 stars being the highest.
Ratings
5.0
Provider listen carefully to you
4.9
Know important info medical history
4.9
Show respect for what you say
4.9
Spend enough time with you
4.9
Rate provider 0-10
4.9
Recommend this provider office
4.9
Provider explain in way you understand
Reviews
01/26/23
As always, Dr. Yamzon takes time and answers all questions. - Verified patient
01/17/23
They all work together - Verified patient
01/17/23
Everything is very good - Verified patient
01/05/23
I recommend this doctor to everyone who needs this type of care - Verified patient
11/27/22
I am very happy with service I received - Verified patient